Samsara BioCapital’s Nkarta NKTX Stock Holding History

Samsara BioCapital’s Portfolio NKTX Stock Details NKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.93M	Hold	3,507,666	–	–	0.82%	15
2026 Q1	$7.4M	Hold	3,507,666	–	–	0.72%	14
2025 Q4	$6.49M	Sell	3,507,666 -260,369	-7%	-$520K	0.67%	17
2025 Q3	$7.8M	Hold	3,768,035	–	–	1.02%	14
2025 Q2	$6.25M	Hold	3,768,035	–	–	1.28%	14
2025 Q1	$6.93M	Hold	3,768,035	–	–	1.24%	15
2024 Q4	$9.38M	Hold	3,768,035	–	–	1.29%	14
2024 Q3	$17M	Hold	3,768,035	–	–	3.27%	8
2024 Q2	$22.3M	Hold	3,768,035	–	–	4.66%	7
2024 Q1	$40.7M	Buy	3,768,035 +900,000	+31%	+$9.36M	6.3%	5
2023 Q4	$18.9M	Hold	2,868,035	–	–	2.94%	8
2023 Q3	$3.99M	Hold	2,868,035	–	–	1.22%	23
2023 Q2	$6.28M	Hold	2,868,035	–	–	1.1%	18
2023 Q1	$10.2M	Hold	2,868,035	–	–	2.1%	11
2022 Q4	$17.2M	Hold	2,868,035	–	–	3.7%	8
2022 Q3	$37.7M	Hold	2,868,035	–	–	8.8%	2
2022 Q2	$35.3M	Buy	2,868,035 +833,333	+41%	+$10.9M	9.42%	2
2022 Q1	$23.2M	Sell	2,034,702 -1	-0%	-$11	5.83%	3
2021 Q4	$31.2M	Hold	2,034,703	–	–	6.06%	4
2021 Q3	$56.6M	Hold	2,034,703	–	–	8.88%	2
2021 Q2	$64.5M	Hold	2,034,703	–	–	7.96%	2
2021 Q1	$66.9M	Hold	2,034,703	–	–	12.35%	1
2020 Q4	$125M	Hold	2,034,703	–	–	12.58%	2
2020 Q3	$61.2M	Buy	+2,034,703	New	+$60M	17.06%	2

Other funds holding NKTX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

GSK plc London $602M AUM

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Samsara BioCapital's NKTX Position: Q2 2026 in Review

Samsara BioCapital held its Nkarta (NKTX) position steady in Q2 2026 at 3,507,666 shares worth $9.93M. The position accounts for 0.82% of the portfolio, ranked #15.

Samsara BioCapital first reported a position in NKTX in Q3 2020 and has held it in 24 quarters since. The position peaked at $125M in Q4 2020. 136 funds tracked by Wall St. Rank hold NKTX as of Q2 2026.

Samsara BioCapital held 3,507,666 shares of Nkarta worth $9.93M as of Q2 2026.
Samsara BioCapital left its Nkarta share count unchanged in Q2 2026.
Nkarta made up 0.82% of Samsara BioCapital's portfolio in Q2 2026, its #15 holding.
Samsara BioCapital first reported a position in Nkarta in Q3 2020 and has held it in 24 quarters since.
Samsara BioCapital's Nkarta position peaked at $125M in Q4 2020.
136 funds tracked by Wall St. Rank held Nkarta as of Q2 2026.

Based on Samsara BioCapital's 13F filing for Q2 2026, filed 14 Aug 2026.